# Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis

> **NCT04118010** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 40 (actual)

## Conditions studied

- Cystic Fibrosis
- Dysbiosis

## Interventions

- **DRUG:** Vitamin D3
- **DRUG:** Placebo vitamin D3
- **DRUG:** Inulin
- **DRUG:** Placebo Inulin

## Key facts

- **NCT ID:** NCT04118010
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-13
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04118010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04118010, "Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04118010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*